KCNQ2
The potassium channel M, which slowly activates and deactivates, is essential for controlling the excitability of neurons. The protein produced by this gene and a similar protein expressed by the KCNQ3 gene, both of which are essential membrane proteins, come together to create the M channel. M1 muscarinic acetylcholine receptors inhibit M channel currents, while retigabine, a novel anti-convulsant medication, activates them. Benign neonatal type 1 epilepsy, also known as benign familial neonatal convulsions type 1, is brought on by errors in this gene.
Full Name | Potassium voltage-gated channel subfamily Q member 2 |
Gene ID | Human: 3785 Mouse: 16536 Rat: 170848 Monkey: 719614 |
UniProt ID | Human: O43526 Mouse: Q9Z351 Rat: O88943 Monkey: F7ASD7 |
Alternative Names | EBN; BFNC; DEE7; EBN1; ENB1; HNSPC; KV7.2; KCNA11; potassium voltage-gated channel subfamily KQT member 2; neuroblastoma-specific potassium channel subunit alpha KvLQT2; potassium channel, voltage gated KQT-like subfamily Q, member 2; voltage-gated potassium channel subunit Kv7.2; KCNQ2; Potassium voltage-gated channel subfamily Q member 2 |
Product List
- Product Category:
- Membrane Protein Stable Cell Lines
- Target Protein: KCNQ2/KCNQ3 Target Family: Voltage Gated Potassium Channel Target Protein Species: Human
- Product Category:
- Membrane Protein Stable Cell Lines
- Target Protein: KCNQ2/KCNQ4 Target Family: Voltage Gated Potassium Channel Target Protein Species: Human
- Product Category:
- Membrane Protein Stable Cell Lines
- Target Protein: KCNQ2 Target Family: Kv7 Target Protein Species: Human Host Cell Type: CHO-K1; HEK293